公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
公司地址 One Baxter Parkway, Deerfield, IL, USA, 60015
電話號碼 +1 224 948-2000
傳真號碼 +1 877 334-2298
公司網頁 https://www.baxter.com
員工數量 37500
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Jeanne K. Mason Executive Vice President and Chief Human Resources Officer -- 21/02/2025
Mr. James W. Borzi Executive Vice President and Chief Supply Chain Officer -- 21/02/2025
Mr. John Terence Rogers Executive Vice President and Chief Financial Officer -- 19/08/2026
Mr. Andrew P. Hider Interim Chief Financial Officer, Director, President, Chief Executive Officer and Interim Group President, Medical Products and Therapies 美元 499.32K 19/08/2026
Mr. David S. Rosenbloom Executive Vice President and General Counsel 美元 760.00K 12/02/2026
Mr. Reazur Rasul Executive Vice President and Group President, Healthcare Systems and Technologies 美元 800.00K 12/02/2026
Ms. Maria Cecilia Soriano Group President, Infusion Therapies & Technologies & Pharmaceuticals -- 12/02/2026
Mr. Bernie Heine Interim Chief Accounting Officer and Controller -- 19/08/2026
 
董事會成員
董事會 職務 更新日期
Ms. Patricia B. Morrison Independent Director 23/03/2026
Mr. Jeffrey A. Craig Independent Director 23/03/2026
Mr. Michael R. Mcdonnell Director 12/02/2026
Ms. Amy A. Wendell Independent Director 23/03/2026
Ms. Nancy M. Schlichting Lead Independent Director 23/03/2026
Mr. D. Brent Shafer Chairman of the Board 19/08/2026
Mr. Andrew P. Hider Interim Chief Financial Officer, Director, President, Chief Executive Officer and Interim Group President, Medical Products and Therapies 19/08/2026
Dr. David S. Wilkes, M.D. Independent Director 23/03/2026
Mr. William A. Ampofo, II Independent Director 23/03/2026
 
所屬ETF (更新日期: 14/11/2026 04:09)
代號 名稱 佔比% ▼ 持有日期
WSMLiShares MSCI World Small-Cap ETF0.01%30/10/2026
DDFDelaware Inv Div & Income0.01%31/01/2023
PALCPacer Lunt Large Cap Mlt Ftr Alt ETF0.01%30/10/2026
AVMCAvantis U.S. Mid Cap Equity ETF0.01%30/10/2026
EQALInvesco Russell 1000 Equal Weight ETF0.01%30/10/2026
GABGabelli Equity Trust0.01%30/06/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.01%30/10/2026
PTLInspire 500 ETF0.01%30/10/2026
IUSInvesco RAFI™ Strategic US ETF0.01%30/10/2026
PTLCPacer Trendpilot™ US Large Cap ETF0.005%30/10/2026
REVSColumbia Research Enhanced Value ETF0.005%31/10/2026
XYLDGlobal X S&P 500® Covered Call ETF0.005%30/10/2026
GRXGabelli Health & Wellness0.005%30/06/2026
OMFLInvesco Russell 1000® Dynamic Mltfct ETF0.005%30/10/2026
ITANSparkline Intangible Value ETF0.004%30/10/2026
QVMLInvesco S&P 500 QVM Multi-factor ETF0.004%30/10/2026
SPYXSttStrt® SPDR® S&P®500FsslFulRsrvFreeETF0.004%30/10/2026
MSMLiShares MSCI USA Small-Cap ETF0.004%30/10/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.004%30/10/2026
IYYiShares Dow Jones US ETF0.004%30/10/2026
  1    2    3    4   5    6    7    8    9    10    11    12  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.